SCOPESCREEN is dedicated to providing top-quality medical products for the fertility, diagnostics, and developmental biology market. Since 1991, Scopescreen has been manufacturing products for evaluating male fertility, with their products employed for high-standard quality control monitoring and screening assays for all types of laboratories and clinics, including large reference and world-leading research labs. ScreenScope's commitment to innovation and improvement drives the development of advanced healthcare testing strategies that reduce screening costs and improve overall lab processes. They furthered this purpose with the acquisition of Bioscreen in 2020. Optimizing fertility, diagnosis, and developmental biology, SCOPESCREEN is the perfect partner for your lab's needs.